M.D., Chief Medical Science Officer, Sema4
Biography
William K. Oh, M.D. is Chief Medical Science Officer at Sema4, a patient-centered health intelligence company focused on precision medicine. He is also an internationally recognized medical oncologist with over 25 years of clinical and translational research experience and leadership roles at major NCI-designated cancer centers. He continues to see cancer patients in his capacity as Clinical Professor of Medicine at Icahn School of Medicine at Mount Sinai. William has authored more than 330 articles, reviews, books and book chapters related to genitourinary cancers. He has conducted multiple clinical cancer trials and has served in key invited roles for the American Society of Clinical Oncology, the American Cancer Society, and the American Urological Association.
AI & Data Science Showcase:
Sema4
Sema4 is a Patient-Centered Health Intelligence Company Leveraging AI, Genomics and Other Deep Data.
REPRESENT: Providing Prec. Oncology Access to All
Sema4 launched the REPRESENT study in community oncology practices caring for patients with advanced cancer in diverse, underserved populations. REPRESENT will perform comprehensive genomic profiling, hereditary cancer testing and clinical data including SDOH and correlate outcomes to these findings.
Session Abstract – PMWC 2022 Silicon Valley
Track 2 - June 29 1.00 P.M.-2.00 P.M.
Panel
Session Abstract – PMWC 2022 Silicon Valley
Track 7 - June 28 10.00 A.M.-1.15 P.M.,Track 7 - June 29 11.00 A.M.-1.15 P.M.,Track 7 - June 30 9.00 A.M.-11.15 A.M.
The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
